Panacea Index Logo

Command Palette

Search for a command to run...

The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes.

Nutrition & diabetes
March 20, 2017
N Wright et al. (5 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the effectiveness of a whole food plant-based (WFPB) diet in reducing BMI and cholesterol in individuals with obesity or overweight and related metabolic conditions.

Results Summary

The WFPB diet led to significant BMI reduction (4.4 kg/m² at 6 months, 4.2 kg/m² at 12 months) and modest cholesterol reduction (0.71 mmol/l at 6 months, 0.55 mmol/l at 12 months) compared to normal care, with no serious harms reported.

Population

Adults aged 35-70 with obesity or overweight and at least one of type 2 diabetes, ischemic heart disease, hypertension, or hypercholesterolemia, from a general practice in Gisborne, New Zealand.

Effective Dosage

Non-energy-restricted WFPB diet with vitamin B12 supplementation; no specific dosage mentioned.

Duration

12 weeks of facilitated meetings, with follow-up at 6 and 12 months.

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
BMI
subjects with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemia
4.4 vs 0.4, difference: 3.9 kg m-2
reduction was greater
#1
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
cholesterol
subjects with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemia
0.71 vs 0.26, difference: 0.45 mmol l-1
reduction was greater
#2
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
BMI
WFPB diet group
4.2 (±0.8) kg m-2
reductions
#3
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
total cholesterol
WFPB diet group
0.55 (±0.54) mmol l-1
reductions
#4
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
BMI, cholesterol and other risk factors
subjects with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemia
-
led to significant improvements
#5
whole food plant-based (WFPB) diet with vitamin B12 supplementation
decrease
weight
-
-
achieved greater weight loss
#6
Abstract

BACKGROUND/OBJECTIVE: There is little randomised evidence using a whole food plant-based (WFPB) diet as intervention for elevated body mass index (BMI) or dyslipidaemia. We investigated the effectiveness of a community-based dietary programme. Primary end points: BMI and cholesterol at 6 months (subsequently extended). SUBJECTS: Ages 35-70, from one general practice in Gisborne, New Zealand. Diagnosed with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemia. Of 65 subjects randomised (control n=32, intervention n=33), 49 (75.4%) completed the study to 6 months. Twenty-three (70%) intervention participants were followed up at 12 months. METHODS: All participants received normal care. Intervention participants attended facilitated meetings twice-weekly for 12 weeks, and followed a non-energy-restricted WFPB diet with vitamin B12 supplementation. RESULTS: At 6 months, mean BMI reduction was greater with the WFPB diet compared with normal care (4.4 vs 0.4, difference: 3.9 kg m-2 (95% confidence interval (CI)±1), P<0.0001). Mean cholesterol reduction was greater with the WFPB diet, but the difference was not significant compared with normal care (0.71 vs 0.26, difference: 0.45 mmol l-1 (95% CI±0.54), P=0.1), unless dropouts were excluded (difference: 0.56 mmol l-1 (95% CI±0.54), P=0.05). Twelve-month mean reductions for the WFPB diet group were 4.2 (±0.8) kg m-2 BMI points and 0.55 (±0.54, P=0.05) mmol l-1 total cholesterol. No serious harms were reported. CONCLUSIONS: This programme led to significant improvements in BMI, cholesterol and other risk factors. To the best of our knowledge, this research has achieved greater weight loss at 6 and 12 months than any other trial that does not limit energy intake or mandate regular exercise.

Medical Subject Headings (MeSH)
AdultAgedBody Mass IndexCholesterolDiabetes Mellitus, Type 2Diet, VegetarianFemaleHumansHypercholesterolemiaHypertensionMaleMiddle AgedMyocardial IschemiaObesityOverweightRisk FactorsTreatment Outcome
Study Links
Quality Scores
Safety90
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations169
Citations/Year21.1
Relative Citation Ratio8.08
NIH Percentile96.9%
Research Impact Scores
APT Score0.95
Weight Score2.22
Normalized Score0.85
Related Supplements